NEWSLETTER SPRING - 1999 ROSTER OF RPSC OFFICERS FOR 1999-2000 ......................…….............….….…1 MEMBERS OF RPSC STANDING COMMITTEES ................…….................……...2 PRESIDENT’S ADDRESS ............................................…….................……….……...3 PAST-PRESIDENT’S ADDRESS .....................…….........................................………4 MINUTES OF THE B.O.D. MIDWINTER MEETING, FT. LAUDERDALE……......4 REPORT: HIGH COUNTRY MEETING, VAIL, …………………………………..…6 SYMPOSIUM: MEDICAL UNIV. OF S. CAROLINA, WASHINGTON DC………..7 MINUTES FROM HOUSE OF DELEGATES MEETING, FT. LAUDERDALE……..9 ELECTIONS ’99: CANDIDATE BIO-SKETCHES……………………………….….13 RPSC PROGRAM FOR ANNUAL SNM.....….............................…..……………….18 REMINDER: UPCOMING MEETINGS ...........................................…….……..…...19 TREASURER’S REPORT..........................................................………………….…..22 **OFFICIAL ELECTION BALLOT**…….…………………………………………..…...23 ROSTER OF RPSC OFFICERS FOR 1999-2000 President John W. Babich, Ph.D. Biostream, Inc. 160 2nd Street Cambridge Cambridge, MA 02142 Phone: 617- 492-5554 FAX: 617-492-5664 E-mail: <[email protected]> President-elect Mark M. Goodman, Ph.D. Emory University Hospital, Radiology Dept. 1364 Clifton Rd. NE Atlanta GA 30322 Phone 404-727-9366 Fax: 404-727-4366 E-mail: <[email protected]> Past-President James Kronauge, Ph.D. Brigham and Women's Hospital, Radiology Department 75 Francis Street, Boston, MA 02115 Phone: 617-732-7171 FAX: 617-734-4757 E-mail: <[email protected]> Secretary/Treasurer Katherine Seifert, RPh, BCNP Syncor International Corporation 20001 Prairie St., Chatsworth, CA 91311 Phone: 818-717-4514 FAX:818-717-4514 E-mail: <[email protected]> Board of Directors (1996-1998) John Lister-James Ann Warbick-Cerone Yu-Shin Ding, Ph.D. Diatech Inc. Health and Welfare Brookhaven National Labs 9 Delta Drive 775 Brookfield Rd. Chemistry Dept. Londonderry, NH 03053 Ottawa K1a 1C1 Upton, NY 11973 Phone: 603 437-8970 Ontario, CA Phone: 516-344-4366 FAX: 603-437-8977 Phone: 613-954-6704 Fax: 516-344-7902 Fax: 613-941-5841 [email protected] Board of Directors (1997-1999) Carolyn Anderson F. F. “Russ” Knapp Robert Wolfangel (314) 362-8427 (615) 574-6225 (314) 895-2203 e-mail: andersoncj@ e-mail: [email protected] e-mail: [email protected] mirlink.wustl.edu Representative SNM House of Delegates (June 1997- June 1999) Suresh Srivastava (516) 344-4459 e-mail: [email protected] Members of RPSC Standing Committees Following is a list of the standing committees dictated by the council’s by-laws with names and phone numbers of their corresponding chairmen and members. If anyone has suggestions, questions or comments concerning the duties performed by these committees they are encouraged to contact the chair or a member. Program Communication Members & Finances Nominating John Babich Mark Goodman Kathy Seifert Jim Kronauge [email protected] [email protected] [email protected] Per Bremer Alan Packard Ron Crowe per.bremer@ [email protected] ron [email protected] isopharma.no Pat Gallagher Steve Mattmuller Henry Van Brocklin [email protected] Tim McCarthy [email protected] A three-day seminar was held on March 10- MESSAGE FROM THE PRESIDENT 13 on "Accomplishments with Medical Isotopes". This conference was a mix Presidents message of policy discussions and scientific Spring 1999 presentations. The issue at hand was the role of government with regard to research Dear Colleagues, involving isotopes and breakthroughs in medical sciences as a result of that research. Welcome back to the renovation of the A number of SNM members participated on Council Part II. In our first installment we different panels. Dr Bob Atcher has kindly mentioned the increasing role the council provided us with a synopsis of this meeting. will be expected to play in the Society. The Dr. Kronauge will report on the annual High roles of advisor, leader, expert, lobbyist and Country meeting, a gathering that usually supporter. The execution of these roles heralds the coming of new appears to hinge on the establishment of a radiopharmaceuticals. The implications of more clearly defined mission for the council Jim's report are intriguing to me and may be and a further clarification of the roles of its to you as well. members, directors and executives. This will be the focus of Phase II. The interval between newsletters has seen the passing of two important figures in the There are definite tasks that the council must field of chemistry related to our field, Dr. engage in. We are adding significantly to the Glenn Seaborg and Dr. Al Wolf. Dr. Wolf large educational commitment of the council has been a central figure in the development and, consequently, the council is attempting of P.E.T. and many of the field's leaders to set up more structured roles for its have been mentored by him or worked membership, board of directors and closely with him. His will be missed by executives. Dr. Henry Kramer of CORAR many. has been kind enough to help me establish an understanding of how CORAR has set up I want to take this opportunity to thank Pat it's "response team" to deal with regulatory Gallagher, Jason Lewis, Tim McCarthy and and other governmental issues. I hope to be Henry Van Brocklin for doing such an able to present an outline of our strategy for outstanding job in putting together our implementing a similar plan at the annual educational program for the upcoming business meeting. Between newsletters I meeting. Jim Kronauge should be have tried to use e-mail to engage the commended for finding those of you council members in assisting in some of courageous enough to throw your hat into these processes. In this regard, we have been the election arena. I also need to contacted by Dr. Fletcher, President of acknowledge Mark Goodman's patience in the Society of Nuclear Medicine, Dr. dealing with the president and his writers Silberstein, Chairman of the Commission on block! Radiopharmaceuticals, as well as the Government Relations office and have been I look forward to seeing many of you in made aware of the need to weigh in on June. certain FDA and NRC issues. To date only a hand full of individuals have responded to John Babich requests made by the council. Message from the Past-President moment of silence began the meeting in recognition of Dr. Al Wolf for his many Join the fun: contributions to the field. Dr. Suresh Srivastava noted the establishment of a As you may know, the Radiopharmaceutical scholarship fund in Dr. Wolf’s memory, and Science Council is dictated by its bylaws to the group suggested the Council hold elections every year for officers to commemorate Dr. Wolf’s years of service serve for two year terms. Next year, being with something more formal, perhaps at the an odd year, there will be openings for three Categorical Seminar in June. members to serve as Board of Directors of the science Council. Nominations for The minutes of the meeting were printed in candidates are made at the mid-winter the Newsletter, and approved by vote of the meeting by the nominating committee and committee. The group was informed that ballots mailed to all members in the spring the RPSC-sponsored Categorical Seminar newsletter. RPSC Board members are scheduled for June 6, 1999 is entitled expected to attend the business meeting and “Neuropharmacology.” Members of the some SNM committee meetings held the day Council may also be interested in another before the national meeting. They may also Categorical Seminar to be held the same day be asked to represent the Council as a voting entitled “Recent Developments in member on another Society’s’ committees. Therapeutic Nuclear Medicine” and is This is the best way to learn what the sponsored by the Therapy Council. Society does and express your opinions on the future of the profession. It is also fun to Dr. Babich led a discussion on the evolving learn what is going on and to develop new role of the Radiopharmaceutical Science and better friendships. At the risk of setting Council and its relation to the Society of an unheard of precedent, we would like to Nuclear Medicine. This evolving role is start the process early this year and extend related to the SNM Policy Discussion paper the offer for members to volunteer to run for which seeks grass roots input and office. Hopefully, this will avoid the participation from a wide group on policy inevitable last minute rush and open up the development. The concomitant change council leadership roles to more members. anticipated for RPSC is a modification in the If you are interested in running for office, primary mission for the Council from an please contact any member of the educational focus to a source for specific nominations committee or myself. Looking expertise and associated policy input. Dr. forward to seeing you all in LA. Babich proposed a more structured Council with specific individuals assigned to projects James F. Kronauge, Past President RPSC or areas. These areas would be somewhat narrow, with many members participating, Minutes from the Radiopharmaceutical limiting the time commitment for any Science Council Midwinter Meeting, individual to a manageable level, February 6, 1999 encouraging participation. Areas or projects will be identified, similar to a list CORAR The February 6, 1999 meeting of the has developed, and Council members are Radiopharmaceutical Science Council was encouraged to “step up to the plate” and called to order by President John Babich identify area(s) where they are willing to with approximately 20 members present. A support the Council with their area of (OMB) recommendation on the DOE budget expertise. was to drop the funds designated to the Mo- 99 initiative due to the fact that Sandia A current issue serves as an example of this production facilities are intended to be concept and a need for RPSC contribution. transferred to the private sector. An RFP on An article appearing in Nuclear Medicine & this will be appearing in the Federal Register Biology proposes various parameters to be soon.